Insufficient scRNA-seq data for expression of USP51 at single-cell level.
Insufficient scRNA-seq data for expression of USP51 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 415.80 | 258 / 258 | 100% | 8.59 | 229 / 230 |
thymus | 100% | 374.17 | 653 / 653 | 99% | 8.44 | 598 / 605 |
prostate | 99% | 207.32 | 242 / 245 | 99% | 5.16 | 498 / 502 |
brain | 100% | 297.61 | 2640 / 2642 | 97% | 6.15 | 686 / 705 |
breast | 99% | 180.77 | 456 / 459 | 98% | 4.36 | 1094 / 1118 |
kidney | 100% | 211.74 | 89 / 89 | 96% | 5.92 | 863 / 901 |
ovary | 100% | 429.18 | 180 / 180 | 95% | 5.58 | 408 / 430 |
skin | 88% | 80.34 | 1586 / 1809 | 96% | 8.43 | 454 / 472 |
pancreas | 94% | 106.96 | 307 / 328 | 83% | 2.36 | 148 / 178 |
lung | 92% | 155.36 | 533 / 578 | 83% | 2.91 | 963 / 1155 |
uterus | 100% | 318.95 | 170 / 170 | 73% | 3.28 | 333 / 459 |
bladder | 100% | 203.38 | 21 / 21 | 47% | 1.16 | 239 / 504 |
esophagus | 91% | 127.01 | 1321 / 1445 | 54% | 1.55 | 98 / 183 |
stomach | 91% | 107.74 | 328 / 359 | 36% | 0.86 | 104 / 286 |
intestine | 96% | 160.78 | 930 / 966 | 23% | 0.49 | 123 / 527 |
eye | 0% | 0 | 0 / 0 | 100% | 11.22 | 80 / 80 |
spleen | 100% | 191.12 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 156.47 | 1186 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 146.72 | 1311 / 1335 | 0% | 0 | 0 / 0 |
liver | 68% | 47.97 | 153 / 226 | 30% | 0.90 | 122 / 406 |
lymph node | 0% | 0 | 0 / 0 | 97% | 2.06 | 28 / 29 |
heart | 92% | 117.50 | 791 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 1.96 | 34 / 45 |
muscle | 27% | 15.95 | 214 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 21% | 42.09 | 195 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0140861 | Biological process | DNA repair-dependent chromatin remodeling |
GO_0010569 | Biological process | regulation of double-strand break repair via homologous recombination |
GO_0006974 | Biological process | DNA damage response |
GO_2001032 | Biological process | regulation of double-strand break repair via nonhomologous end joining |
GO_0006281 | Biological process | DNA repair |
GO_0010564 | Biological process | regulation of cell cycle process |
GO_0006508 | Biological process | proteolysis |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0140950 | Molecular function | histone H2A deubiquitinase activity |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0042393 | Molecular function | histone binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | USP51 |
Protein name | Ubiquitin carboxyl-terminal hydrolase (EC 3.4.19.12) Ubiquitin carboxyl-terminal hydrolase 51 (EC 3.4.19.12) (Deubiquitinating enzyme 51) (Ubiquitin thioesterase 51) (Ubiquitin-specific-processing protease 51) |
Synonyms | |
Description | FUNCTION: Specifically deubiquitinates 'Lys-14' (H2AK13Ub) and 'Lys-16'(H2AK15Ub) of histone H2A regulating the DNA damage response at double-strand breaks (DSBs) . USP51 is recruited to chromatin after DNA damage and regulates the dynamic assembly/disassembly of TP53BP1 and BRCA1. Exhibits also activity for 'Lys-27' or 'Lys-63'-linked di-ubiquitin . . FUNCTION: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes. . |
Accessions | Q70EK9 ENST00000500968.4 ENST00000586165.1 A0A1B0GVA6 |